测定5-氯-2戊酮和环丙基甲基酮的物化性质:密度、黏度、摩尔体积、热膨胀系数和表面张力。测定5-氯-2-戊酮(1)+环丙基甲基酮(2)二元体系的汽液相平衡(VLE),并应用Aspen Plus V11中Van Laar方程、Wilson方程和NRTL方程对实验数据进行关联...测定5-氯-2戊酮和环丙基甲基酮的物化性质:密度、黏度、摩尔体积、热膨胀系数和表面张力。测定5-氯-2-戊酮(1)+环丙基甲基酮(2)二元体系的汽液相平衡(VLE),并应用Aspen Plus V11中Van Laar方程、Wilson方程和NRTL方程对实验数据进行关联,回归得到二元交互参数。实验结果通过热力学一致性检查。该研究不仅补充了汽液相平衡数据库,也为5-氯-2-戊酮与环丙基甲基酮的分离提供热力学数据。展开更多
Objective: To explore the mechanism by which ghrelin regulates insulin sensitivity through modulation of miR-455-5p in hepatic cells. Methods: HepG2 cells were treated with or without DAG (1 μM). Glucose consumption,...Objective: To explore the mechanism by which ghrelin regulates insulin sensitivity through modulation of miR-455-5p in hepatic cells. Methods: HepG2 cells were treated with or without DAG (1 μM). Glucose consumption, intracellular glycogen content, phosphorylation of PI3K and Akt stimulated by insulin, expression of miR-455-5p, as well as IGF-1R protein level were analyzed. In addition, bioinformatic analysis, dual luciferase reporter assay, miR- 455-5p mimic or inhibitor treatment was conducted to investigate the molecular mechanisms. Results: High glucose treatment upregulated miR-455-5p expression but reduced glucose consumption and glycogen content. DAG reversed the effect of high glucose on glucose metabolism, increased protein level of IGF-1R and phosphorylation of PI3K/Akt stimulated by insulin, as well as downregulated miR-455-5p expression. Bioinformatic analysis indicated IGF-1R was the target of miR-455-5p. Dual luciferase reporter assay, as well as transfection with miR-455-5p mimic/inhibitor confirmed that DAG activated IGF-1R/PI3K/Akt signaling via inhibiting miR-455-5p. Conclusion: DAG improves insulin resistance via miR-455-5p- mediated activation of IGF-1R/PI3K/Akt system, suggesting that suppression of miR-455-5p or activation of DAG may be potential targets for T2DM therapy.展开更多
采用水热-煅烧法制备了磁性镍铁尖晶石载体NiFe_(2)O_(4),再采用浸渍-还原法在载体上负载Ru纳米粒子制备Ru/NiFe_(2)O_(4)催化剂。采用X射线衍射(XRD)、N2吸附-脱附(BET)、NH3程序升温脱附(NH3-TPD)、H_(2)程序升温还原(H_(2)-TPR)、X...采用水热-煅烧法制备了磁性镍铁尖晶石载体NiFe_(2)O_(4),再采用浸渍-还原法在载体上负载Ru纳米粒子制备Ru/NiFe_(2)O_(4)催化剂。采用X射线衍射(XRD)、N2吸附-脱附(BET)、NH3程序升温脱附(NH3-TPD)、H_(2)程序升温还原(H_(2)-TPR)、X射线光电子能谱(XPS)和电感耦合等离子体发射光谱(ICP-OES)测试对催化剂进行表征分析。结果表明,Ru/NiFe_(2)O_(4)催化剂表面氧物种丰富,相较于载体,负载Ru后催化剂比表面积和表面酸量增加,Ru与载体存在相互作用,这可能是催化剂高活性和高稳定性的关键。将催化剂用于5-羟甲基糠醛(HMF)的选择性氧化,负载Ru后,催化剂催化活性显著提升。对反应条件进行优化,在添加0.08 g KHCO3,氧化剂O2压力为1 MPa,反应温度为80℃,使用0.1 g Ru/NiFe_(2)O_(4)催化剂,在水溶液中反应12 h HMF能完全转化,2,5-呋喃二甲酸(FDCA)产率为98.1%。Ru/NiFe_(2)O_(4)循环使用5次后仍能保持较高的活性,催化剂上活性组分Ru不易浸出,并且催化剂具有磁性能便于与反应溶液分离。为今后工业化催化HMF高效选择性氧化合成FDCA提供参考。展开更多
文摘测定5-氯-2戊酮和环丙基甲基酮的物化性质:密度、黏度、摩尔体积、热膨胀系数和表面张力。测定5-氯-2-戊酮(1)+环丙基甲基酮(2)二元体系的汽液相平衡(VLE),并应用Aspen Plus V11中Van Laar方程、Wilson方程和NRTL方程对实验数据进行关联,回归得到二元交互参数。实验结果通过热力学一致性检查。该研究不仅补充了汽液相平衡数据库,也为5-氯-2-戊酮与环丙基甲基酮的分离提供热力学数据。
基金Changshu Science and Technology Plan(Social Development)Project(No.CS202130)Key Project of Changshu No.2 People’s Hospital(No.CSEY2021007)。
文摘Objective: To explore the mechanism by which ghrelin regulates insulin sensitivity through modulation of miR-455-5p in hepatic cells. Methods: HepG2 cells were treated with or without DAG (1 μM). Glucose consumption, intracellular glycogen content, phosphorylation of PI3K and Akt stimulated by insulin, expression of miR-455-5p, as well as IGF-1R protein level were analyzed. In addition, bioinformatic analysis, dual luciferase reporter assay, miR- 455-5p mimic or inhibitor treatment was conducted to investigate the molecular mechanisms. Results: High glucose treatment upregulated miR-455-5p expression but reduced glucose consumption and glycogen content. DAG reversed the effect of high glucose on glucose metabolism, increased protein level of IGF-1R and phosphorylation of PI3K/Akt stimulated by insulin, as well as downregulated miR-455-5p expression. Bioinformatic analysis indicated IGF-1R was the target of miR-455-5p. Dual luciferase reporter assay, as well as transfection with miR-455-5p mimic/inhibitor confirmed that DAG activated IGF-1R/PI3K/Akt signaling via inhibiting miR-455-5p. Conclusion: DAG improves insulin resistance via miR-455-5p- mediated activation of IGF-1R/PI3K/Akt system, suggesting that suppression of miR-455-5p or activation of DAG may be potential targets for T2DM therapy.
文摘采用水热-煅烧法制备了磁性镍铁尖晶石载体NiFe_(2)O_(4),再采用浸渍-还原法在载体上负载Ru纳米粒子制备Ru/NiFe_(2)O_(4)催化剂。采用X射线衍射(XRD)、N2吸附-脱附(BET)、NH3程序升温脱附(NH3-TPD)、H_(2)程序升温还原(H_(2)-TPR)、X射线光电子能谱(XPS)和电感耦合等离子体发射光谱(ICP-OES)测试对催化剂进行表征分析。结果表明,Ru/NiFe_(2)O_(4)催化剂表面氧物种丰富,相较于载体,负载Ru后催化剂比表面积和表面酸量增加,Ru与载体存在相互作用,这可能是催化剂高活性和高稳定性的关键。将催化剂用于5-羟甲基糠醛(HMF)的选择性氧化,负载Ru后,催化剂催化活性显著提升。对反应条件进行优化,在添加0.08 g KHCO3,氧化剂O2压力为1 MPa,反应温度为80℃,使用0.1 g Ru/NiFe_(2)O_(4)催化剂,在水溶液中反应12 h HMF能完全转化,2,5-呋喃二甲酸(FDCA)产率为98.1%。Ru/NiFe_(2)O_(4)循环使用5次后仍能保持较高的活性,催化剂上活性组分Ru不易浸出,并且催化剂具有磁性能便于与反应溶液分离。为今后工业化催化HMF高效选择性氧化合成FDCA提供参考。
